CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 65 filers reported holding CHEMOCENTRYX INC in Q1 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,877,000 | -3.4% | 253,230 | -29.1% | 1.25% | -16.8% |
| Q1 2020 | $14,359,000 | +559.6% | 357,379 | -26.1% | 1.50% | +60.4% |
| Q3 2014 | $2,177,000 | +31.5% | 483,741 | +93.7% | 0.94% | +8.1% |
| Q1 2014 | $1,656,000 | -71.4% | 249,700 | -75.0% | 0.86% | -78.8% |
| Q4 2013 | $5,790,000 | – | 1,000,000 | – | 4.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |